Mediworld Middle East

 Did you know? The first #wearable #pacemaker was developed in 1957 and weighed about 100 grams! Today, thanks to advancements in medical technology, pacemakers are not only much smaller but also come with wireless capabilities, allowing doctors to monitor patients remotely. This innovation has significantly improved the quality of life for millions of people worldwide. How do you think wearable tech will evolve in the next decade? Share your thoughts! #MedTech #Innovation #Healthcare #Revolution #dubai #Uae

AI: Shaping the Future of Breast Cancer Screening! A recent review article in Trends in Cancer highlights how #artificialintelligence (#AI) is revolutionizing breast cancer screening and risk-reducing strategies. AI is now being used to analyze mammographic images, uncovering features that could be stronger predictors of breast cancer risk than any other known factor. Key Insights: Mammographic Density: Women with higher mammographic density face a greater risk of breast cancer and the "masking effect," which makes detection harder. AI Advancements: AI methods are identifying mammographic features that help predict future breast cancer diagnoses, offering new opportunities to tailor screening and prevention strategies. “A woman with mammographic features associated with a high risk of breast cancer detection could benefit from more frequent screening or risk-reducing medication,” says Erik Thompson. Personalized Screening: AI can help determine which women might benefit from more frequent screenings or supplementary imaging like MRI or ultrasound. The study emphasizes the need to understand the pathobiology of these AI-generated features to establish their relevance to #breastcancer risk. This knowledge is crucial for future efforts to reduce risk and improve early detection. Join the Conversation: How do you see AI transforming healthcare, particularly in early disease detection? Share your thoughts and experiences below! #BreastCancer #Awareness #AIinHealthcare #Innovation #EarlyDetection #HealthTech #CancerResearch

Sleep Cycle is excited to announce its collaboration with researchers from the University of Cambridge and UCL) on a pioneering study exploring the links between navigation, sleep disruptions, and early detection of Alzheimer’s disease. This innovative research aims to leverage mobile-based sensing data to aid in early diagnosis. Key Highlights: Innovative Approach: The study uses phone apps to capture changes in navigation and sleep patterns, offering a less burdensome and scalable method for early Alzheimer’s detection. “Phone apps offer a new approach that allows changes in these behaviours to be captured in and around people’s own homes,” said Dr. Abhirup Ghosh. Comprehensive Data: Sleep Cycle provides premium access to its app, combining sleep data with navigational data to create machine-learning models for early identification. Mission-Driven: Mikael Kågebäck, PhD, CTO at Sleep Cycle, stated, “Our mission is to improve health worldwide through sleep, and this partnership is an incredible opportunity to make a real difference.” The study began in August 2024 with an initial cohort of 50-60 participants, focusing on metrics like time asleep, sleep efficiency, and snoring. These will be analyzed alongside navigational data and other cognitive tests. Looking Ahead: This research could greatly aid efforts to detect Alzheimer’s disease from its earliest stages, potentially transforming how we approach early diagnosis and treatment. Join the Conversation: Do you think technology can play a significant role in early disease detection? Share your thoughts and experiences below! #AlzheimersResearch #SleepTechnology #Innovation #Healthcare #MachineLearning #EarlyDetection

Royal Philips and University Hospitals Sussex NHS Foundation Trust have successfully completed a pilot project using the Philips ePatch and #AI-powered arrhythmia ECG analysis platform, Philips Cardiologs. This marks the first NHS project to monitor heart patients with this #innovative technology, offering a new era of heart health monitoring. Key Highlights: Extended Monitoring: The ePatch allows up to 14 days of continuous ECG monitoring, increasing the likelihood of diagnosing heart rhythm problems. “The pro-longed wear of the ePatch increases the likelihood of diagnosing heart rhythm problems,” said Dr. Mark Tanner. Patient-Friendly Design: Comfortable and splash-proof, the ePatch enables patients to maintain their daily routines without the inconvenience of traditional Holter monitors. AI-Enhanced Analysis: Philips Cardiologs uses AI to detect arrhythmias like Atrial Fibrillation, often missed by traditional monitors. This enhances the cardiology team's ability to diagnose and treat patients effectively. Looking Ahead: Mark Leftwich, Managing Director Philips UK and Ireland, highlighted the potential of this technology to shift care from hospitals to community settings, aligning with Labour’s 10-year plan to transform the NHS. “Wearable innovation like that leveraged at Sussex could help to transform the NHS and provide better care for more people with potentially life-threatening conditions.” Join the Conversation: Do you think wearable technology can significantly improve healthcare outcomes? Share your thoughts and experiences below! #HealthcareInnovation #WearableTech #HeartHealth #AIinHealthcare #Philips #NHS

At Formnext - Where ideas take shape 2024, LPE proudly announced the addition of a second Axtra3D Lumia X1 printer, making it the first company worldwide to operate two of these advanced machines. This investment is set to meet the growing demands of industries like #aerospace, #motorsport and #healthcare, where precision and efficiency are key. Key Benefits: Reduced Lead Times: The new printer enhances production capabilities, ensuring faster turnaround for complex designs. Advanced Technology: Axtra3D’s Hybrid PhotoSynthesis (HPS) technology combines SLA and DLP for precision, speed, and material versatility. High-Performance Materials: Supports biocompatible, chemical-resistant, and sterilisable polymers for healthcare applications. Patrick Walls, Engineering Director at LPE, stated, “This investment allows us to meet the growing needs of our healthcare clients with even greater speed, precision, and flexibility.” The addition of the second printer reinforces LPE’s commitment to providing cutting-edge solutions and maintaining the highest standards of quality. Looking Ahead: LPE’s ISO 13485 accreditation ensures adherence to international quality standards, particularly in medical device manufacturing. This expansion not only addresses high-volume demands but also supports the production of ESD-compliant parts for sensitive electronics. #AdditiveManufacturing #3DPrinting #Innovation #Healthcare #Aerospace #LPE

Exciting news from Boston Micro Fabrication - BMF! They've opened the UltraThineer Lab in Maynard, Massachusetts, to revolutionize cosmetic dentistry with ultra-thin veneers. Here’s why this is a big deal: #Advanced Technology: The lab uses BMF’s projection micro stereolithography (PµSL) to create veneers three times thinner than traditional ones. Conservative Dentistry: These veneers preserve natural teeth, offering subtle enhancements with minimal tooth reduction. FDA Approved: With FDA 510(k) clearance, BMF is setting new standards in dental aesthetics. Patient Benefits: UltraThineer veneers are just 0.08 mm thick, providing a precise fit and preserving enamel. John Kawola, CEO of BMF, highlights the impact of their ultra-high precision technology in making cosmetic dentistry less invasive and more comfortable. This innovation is a game-changer for both dentists and patients! “Our approach to innovation has centered on applications where our ultra-high precision technology can make the biggest impact. Following FDA clearance of the UltraThineer material, the UltraThineer Lab allows us to meet the demand for thinner and less invasive veneers,” said John Kawola, CEO-Global, BMF. “While additive manufacturing is already proven across multiple dental applications, such as orthodontic aligners, UltraThineer was designed to offer a more seamless alternative to traditional veneers giving dentists and patients a more comfortable and less invasive option for cosmetic dentistry.” "I believe it is important to preserve natural, healthy teeth while offering patients subtle enhancements like shade changes and shape adjustments. Traditional veneering processes often require significant tooth reduction and can cause sensitivity to the teeth,” said Jessica Birrell, owner of Capture Dental Arts. “With UltraThineer's ultra-thin, printed zirconia veneers, conservative dentistry is now redefining and simplifying the process, making conservative veneering more accessible than ever before." What are your thoughts on this breakthrough in dental technology? Share your experiences and insights in the comments! #DentalInnovation #CosmeticDentistry #3DPrinting #HealthcareTech #PatientCare #BMFTech

Neuroelectrics and Neuronostics have teamed up to bring an integrated EEG solution to the #pharmaceutical, CRO and academic sectors! What This Means: High-Quality Data: Combining Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ advanced analytics for precise and actionable insights. Streamlined Clinical Trials: The platform enhances cohort identification, streamlines protocol design, and ensures efficient and impactful trials. Key Features: Targeted Cohort Identification: Identifies participants with the highest seizure burden through a brief 20-minute EEG. Comprehensive Data Analysis: Certified neurophysiologists and cloud-based tools deliver robust EEG insights. Optimised Protocol Design: Experts collaborate to create trial protocols aligned with study goals. John Terry, Managing Director at Neuronostics: “This collaboration with Neuroelectrics creates a powerful offering that will make clinical trials more efficient and effective.” Ana Maiques, CEO of Neuroelectrics: “Our partnership with Neuronostics enables breakthroughs in #neurology and #psychiatry.” #dubai #uae

Juleb - Digital Pharma Company, a pioneering Saudi company in the #pharmaceutical sector, is redefining industry standards by expanding its innovative solutions to five countries! Key Achievements: Track and Trace Compliance: Juleb is the first to offer a fully integrated solution for SFDA compliance, ensuring seamless traceability and enhancing transparency. Massive Reach: Managing over one million square feet of pharmaceutical warehouses and serving 700+ pharmacies. Saudi Vision 2030: Contributing to the national ambition by enhancing operational efficiency and optimizing supply chains. Innovative Solutions: Diverse Services: From point-of-sale systems to inventory management and business intelligence tools, Juleb caters to #pharmacies, #distributors & manufacturers. Recognition and Future Plans: Saudi Tech Seal: Awarded for excellence in local tech innovation, strengthening Saudi Arabia’s global tech and healthcare presence. AI Investments: Plans to integrate AI-driven solutions to enhance decision-making and operations. Discussion Time: How do you see technology transforming the pharmaceutical industry? Share your insights and experiences below! #Innovation #Pharmaceuticals #Healthcare #SaudiVision2030 #Technology #AI

Aptamer Group has announced the addition of three esteemed experts to its Scientific Advisory Board (SAB): Dr. Paloma Giangrande, Dr. Louis Allott & Dr. Adam Hargreaves. Key Highlights: Focused on advancing targeted therapeutic delivery vehicles Strengthened collaboration across diverse application areas Enhanced strategies, scientific approaches, and clinical advancements Meet the New Members: Dr. Paloma Giangrande: Expert in nucleic acid therapeutics and RNA aptamers Dr. Louis Allot: Specialist in radiopharmaceutical development Dr. Adam Hargreaves: Experienced in preclinical and translational pharmaceuticals Aptamer's Vision: With this expanded team, Aptamer Group is poised to make significant strides in healthcare and beyond. The insights from these new members will bolster the company's mission to deliver groundbreaking solutions for a healthier future. Dr Arron Tolley, Chief Executive Officer of Aptamer Group said: “As Aptamer furthers our strategic programmes across targeted therapies, diagnostics and fast-moving consumer goods, the landscape for each of these specialised fields is rapidly evolving. The new appointments to our Scientific Advisory Board bring additional focus to our strategy and will give valuable insights to support the advancement of our high-value assets and programmes towards the clinic. These appointments underscore our dedication to capitalise on current assets and the strength of our platform to maximise shareholder value. The enlarged SAB aims to deepen our understanding of clinical processes and clinical applications of our technology whilst ensuring we keep abreast of any new important developments that could offer significant value for Aptamer in the future.” Engage with the Community: What do you think about the impact of advancements in therapeutic delivery on the future of healthcare? Share your thoughts and experiences in the comments below! Let's foster discussion and innovation together. #Innovation #Healthcare #Therapeutics #LifeSciences #ScientificAdvisoryBoard #AptamerGroup

Did you know? Researchers have built the tiniest walking #robot ever! Its mission? To be small enough to interact with visible light waves and independently navigate tricky spots—like maneuvering through tissue samples to capture images or measure forces in some of the body's tiniest structures. "A walking robot that's small enough to interact with and shape light effectively takes a microscope's lens and puts it directly into the microworld," said paul mceuen, professor of physical science emeritus, who led the team. The combination of #maneuverability, #flexibility and sub-diffractive optical technology create a significant advance in the field of robotics, the researchers said. This little wonder could revolutionize how we study and treat the human body, taking #imaging and #diagnostics to an entirely new (and microscopic) level! The research was made possible by the Cornell Center for Materials Research, the National Science Foundation and the Cornell NanoScale Science and Technology Facility. Big things come in tiny packages! Research by - Cornell University The team's paper, "Magnetically Programmed Diffractive Robotics," published in Science. #MedicalInnovation #TinyTech #RoboticsInMedicine #MediworldUpdates #innovation #med #medical